Membership Directory

Altus Pharmaceuticals Inc.

Category: Drug Development
Phone: 617-299-2900
Fax: 617-299-2999
Website: http://www.altus.com

Altus Pharmaceuticals Inc.. has developed a unique, powerful and proprietary platform technology, known as "Crystalomics," to enable the rapid commercialization of high-value protein-based products. The Company's primary focus is on the $295 billion pharmaceutical industry, where the technology is designed to significantly accelerate the development of both large and small molecule drugs. In the large molecule area, the technology for developing protein-based drugs has not kept pace with the tremendous number of promising drug candidates arising out of the Human Genome Project and related proteomics efforts. The Crystalomics platform addresses major limitations in protein drug development by enabling Altus to transform protein candidates into their crystalline state, the preferred state for producing, formulating and delivering drugs. The Company is also using its Crystalomics platform to independently develop anew class of orally delivered large molecule drugs for use as lumenal therapies. The Company leverages its technology through its internal drug development effort and has numerous collaborations with leading organizations including Triangle Pharmaceuticals, Inc., The Cystic Fibrosis Foundation and several of the foremost health care and biopharmaceutical companies.

Back to list

Recent Jobs